You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 8, August 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Papers
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (75)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Familial Nonmedullary Thyroid Cancer

An Emerging Entity That Warrants Aggressive Treatment

Richard F. Grossman, MD; Shih-Hsin Tu, MD; Quan-Yang Duh, MD; Allan E. Siperstein, MD; Faina Novosolov; Orlo H. Clark, MD

Arch Surg. 1995;130(8):892-899.


Abstract

Objective
To determine whether familial nonmedullary thyroid carcinoma behaves like sporadic carcinoma of follicular cell origin.

Design
Retrospective review.

Setting
University medical center.

Patients
Fourteen patients were treated for familial nonmedullary thyroid carcinoma between 1980 and 1994. Thirteen families were identified, with 30 affected individuals.

Interventions
Patients were treated with total or completion total thyroidectomy. Thirteen additional operations were performed to control recurrent disease.

Main Outcome Measures
Stage, recurrence, and survival. Patients were followed up for a mean of 6.5 years.

Results
In our 14 patients, 13 tumors were multifocal, and six of these were bilateral. The incidences of lymph node metastasis and local invasion were both 57% (n=8). Seven patients (50%) had recurrences during follow-up.

Conclusions
Familial nonmedullary thyroid carcinoma has a high incidence of multifocality and invasion and a high rate of local recurrence. Aggressive initial treatment and careful follow-up seem to be indicated.

(Arch Surg. 1995;130:892-899)



Author Affiliations

From the Department of Surgery, Mount Zion Medical Center of the University of California at San Francisco (Drs Grossman, Duh, Siperstein, and Clark and Ms Novosolov), and Department of Surgery, Cathay General Hospital, Taipei, Taiwan, Republic of China (Dr Tu).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Germline Mutation (A339V) in Thyroid Transcription Factor-1 (TITF-1/NKX2.1) in Patients With Multinodular Goiter and Papillary Thyroid Carcinoma
Ngan et al.
JNCI J Natl Cancer Inst 2009;101:162-175.
ABSTRACT | FULL TEXT  

Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity
Capezzone et al.
Endocr Relat Cancer 2008;15:1075-1081.
ABSTRACT | FULL TEXT  

Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer
McKay et al.
J. Med. Genet. 2004;41:407-412.
ABSTRACT | FULL TEXT  

The Genetics of Hereditary Nonmedullary Thyroid Carcinoma
Malchoff and Malchoff
J. Clin. Endocrinol. Metab. 2002;87:2455-2459.
FULL TEXT  

Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma
Lesueur et al.
J. Med. Genet. 2002;39:260-265.
ABSTRACT | FULL TEXT  

Increased Risk for Nonmedullary Thyroid Cancer in the First Degree Relatives of Prevalent Cases of Nonmedullary Thyroid Cancer: A Hospital-Based Study
Pal et al.
J. Clin. Endocrinol. Metab. 2001;86:5307-5312.
ABSTRACT | FULL TEXT  

Familial non-medullary thyroid cancer in Iceland
HRAFNKELSSON et al.
J. Med. Genet. 2001;38:189-191.
FULL TEXT  

Papillary Thyroid Carcinoma Associated with Papillary Renal Neoplasia: Genetic Linkage Analysis of a Distinct Heritable Tumor Syndrome
Malchoff et al.
J. Clin. Endocrinol. Metab. 2000;85:1758-1764.
ABSTRACT | FULL TEXT  

Genetic Heterogeneity in Familial Nonmedullary Thyroid Carcinoma: Exclusion of Linkage to RET, MNG1, and TCO in 56 Families
Lesueur et al.
J. Clin. Endocrinol. Metab. 1999;84:2157-2162.
ABSTRACT | FULL TEXT  

Familial Nonmedullary Thyroid Carcinomas: A Heterogeneous Syndrome with Different Natural History and Variable Long-Term Prognosisb
Cetta
J. Clin. Endocrinol. Metab. 1997;82:4274a-4275.
FULL TEXT  

Thyroid Gland Abnormalities in Patients with the Syndrome of Spotty Skin Pigmentation, Myxomas, Endocrine Overactivity, and Schwannomas (Carney Complex)
Stratakis et al.
J. Clin. Endocrinol. Metab. 1997;82:2037-2043.
ABSTRACT | FULL TEXT  

Two Families with an Autosomal Dominant Inheritance Pattern for Papillary Carcinoma of the Thyroid
Burgess et al.
J. Clin. Endocrinol. Metab. 1997;82:345-348.
ABSTRACT | FULL TEXT  

Familial Nonmedullary Thyroid Cancer: An Emerging Entity That Warrants Aggressive Treatment
Takami et al.
Arch Surg 1996;131:676-676.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.